biontech.de (BNTX): Operating Profitability

Corporate company logo of BioNTech SE (BNTX)

The decline in COVID-19 vaccine revenues has impacted the price action of BioNTech SE (BNTX), where the indicator level stands at -61.20. The operating profit margin demonstrates a dependency on the success of the oncology pipeline and R&D expenditures. Cash flow instability, driven by a limited number of commercial products, complicates forecasting; consequently, BioNTech SE (BNTX) relies on extensive reserves and strategic partnerships to advance medical development.

BNTX - biontech.de Operating Profit Ratio over the range 07/04/2022 - 11/19/2026

Analytical breakdowns for BioNTech SE

- price and consensus price forecast:
- stock exchange capitalization data:
Fundamental company valuation:BioNTech Group
Finished products of BioNTech Pharma

To identify fundamental sector leaders, the analyst evaluates the business's ability to convert revenue into operating income before taxes and interest payments. This metric measures the efficiency of production cost management, which is critical for BioNTech SE (BNTX) when scaling oncology vaccines through a network of external contractors, reflecting the model's resilience to vendor changes via the core operating profit margin.

Competitor analysis for BioNTech SE

ARGX (argenx N.V.) - Operating Margin|ABIVAX (ABVX) - Profitability of Operations|Operating Margin ADMA|Operating Profit Ratio PTGX|Operating Profitability Immunovant Corp IMVT|Operating Margin Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Operating Profitability|Profitability of Operations Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Operating Sales Margin|Aurinia Pharmaceuticals Inc. (AUPH) - Operating Margin|Operating Sales Margin BCRX|Operating Return on Sales Vera Therapeutics Inc VERA|Operating Sales Margin DNTH (Dianthus Pharma)|Profitability of Operations Pharvaris N.V.|AbCellera Biologics Inc - Operating Sales Margin|Tourmaline Bio (TRML) - Operating Return on Sales|PGEN - Operating Profitability|Operating Profit Rate PHAR (Pharming Group NV)|NKTR: Operating Margin|Upstream Bio Corp - Operating Profit Rate|Operating Profitability Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Profitability of Operations|Operating Margin GOSS|Operating Sales Margin KalVista Pharmaceuticals, Inc. KALV|Operating Profitability Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Operating Return on Sales|SVRA - Operating Profitability|Rigel Pharmaceuticals - Operating Profit Ratio|AnaptysBio Corp (ANAB) - Operating Profitability|ATXS - Profitability of Operations|Operating Profitability enGene Holdings Inc.|RAPT: Operating Profit Rate|Operating Margin JBIO|Operating Sales Margin aclaristx.com ACRS|Operating Profitability Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Operating Return on Sales|Cabaletta Bio, Inc - Operating Margin|Operating Return on Sales Ventyx Biosciences|THTX (theratech.com) - Operating Sales Margin|Operating Sales Margin Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Operating Margin|Operating Return on Sales Agenus Inc. AGEN|Operating Sales Margin CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Operating Profit Rate|Operating Profitability atyrpharma.com ATYR|Operating Margin Adagene Corp ADAG|IMA - Operating Profitability|Operating Profit Rate STTK (Shattuck Labs)|EQ: Operating Margin|Connect Biopharma (CNTB) - Operating Margin|Operating Profitability Immunic|Operating Margin atarabio.com|Operating Margin IFRX|Operating Margin X4 Pharma (XFOR)|Operating Margin ACET (adicetbio.com)|Operating Margin Celularity Inc. CELU|INMB - Operating Profitability|Operating Profit Rate BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Operating Sales Margin|Operating Sales Margin SAB Biotherapeutics Inc.|Operating Sales Margin AKTX|Operating Sales Margin enlivex.com (ENLV)|Operating Profitability Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Operating Profitability Margin|Operating Margin EDSA (Edesa Biotech Corp)|Profitability of Operations iBio (IBIO)|CARM - Operating Profitability|XTL Biopharmaceuticals (XTLB) - Operating Sales Margin|BOLT: Operating Margin|Operating Sales Margin HCW Biologics Inc.|Operating Profitability Aptevo|Return on Sales by Operating Profit AIM (AIM ImmunoTech, Inc.)|Operating Margin ADTX|Profitability of Operations GRI Bio Corp|Operating Margin XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Operating Return on Sales|Revelation Biosciences Corp - Operating Margin|INDP (Indaptus Therapeutics, Inc.) - Return on Sales by Operating Profit|SCNI: Operating Margin|CALI - Profitability of Operations|AFMD (Affimed N.V.) - Operating Margin|Operating Profitability ALLK|Operating Sales Margin HOOK (HOOKIPA Pharma, Inc.)|IGMS - Operating Return on Sales|Operating Profitability iTeos ITOS|Ocean Bio - Operating Profitability|TC BioPharm Ltd - Operating Margin|Operating Return on Sales thirdharmonicbio.com